oral glp 1 analogues glp-1 Development of an orally delivered receptor agonist through peptide engineering and drug delivery to treat chronic disease Oral GLP-1s rapidly expanding user – Oral Treatment of Obesity by

Revenko, A., Carnevalli, L

Diabetes Risk There is a potential risk of developing insulin resistance or diabetes with prolonged use of sermorelin

Pros: Free from parabens and approved by the FDA for safety

Synthetic alpha-MSH analog activating MC1R (melanogenesis skin pigmentation, UV photoprotection) and MC4R (appetite suppression, energy balance, sexual function)

Apovian said some people using compounded or counterfeit medications do not have obesity and may be using the drugs strictly to lose a few pounds

Potential contraindications include: Pregnant or breastfeeding women should not undergo Epithalon therapy, as there is insufficient research to confirm safety for mother and child